Intestinal Dysbiosis and Biotin Deprivation Induce Alopecia through Overgrowth of Lactobacillus murinus in Mice
Year: 2017
Type: article
Abstract: Metabolism by the gut microbiota affects host physiology beyond the gastrointestinal tract. Here, we find that antibiotic-induced dysbiosis, in particular, overgrowth of Lactobacillus murinus (L. murinus), impaired gut metabolic function and led to the development of alopecia. While deprivation of dietary biotin per se did not affect skin physiology, its simultaneous treatment with vancomycin resulted in hair loss in specific pathogen-free (SPF) mice. Vancomycin treatment induced the accumulation of L. murinus in the gut, which consumes residual biotin and depletes available biotin in the gut. Consistently, L. murinus induced alopecia when monocolonized in germ-free mice fed a biotin-deficient diet. Supplementation of biotin can reverse established alopecia symptoms in the SPF condition, indicating that L. murinus plays a central role in the induction of hair loss via a biotin-dependent manner. Collectively, our results indicate that luminal metabolic alterations associated with gut dysbiosis and dietary modifications can compromise skin physiology.
Source: Cell Reports
Authors: Atsushi Hayashi(Conceptualization, Formal analysis, Investigation, Methodology, Visualization, Writing – original draft, Writing – review & editing), Yohei Mikami(Conceptualization, Investigation, Methodology, Visualization, Writing – original draft, Writing – review & editing), Kentaro Miyamoto(Formal analysis, Investigation, Methodology, Visualization), Nobuhiko Kamada(Writing – original draft, Writing – review & editing), Toshiro Sato(Project administration, Writing – original draft), Shinta Mizuno(Project administration), Makoto Naganuma(Project administration), Toshiaki Teratani(Methodology), Ryo Aoki(Methodology), Shinji Fukuda(Investigation, Methodology, Visualization), Wataru Suda(Project administration), Masahira Hattori(Project administration), Masayuki Amagai(Project administration), Manabu Ohyama(Supervision), Takanori Kanai(Conceptualization, Funding acquisition, Investigation, Supervision, Writing – original draft, Writing – review & editing)
Institutions: Keio University, Miyarisan Pharmaceutical Co., Ltd. (Japan), University of Michigan, Michigan Medicine, Ezaki Glico (Japan), Institute for Advanced Biosciences, Keio University, The University of Tokyo, Waseda University, Japan Agency for Medical Research and Development, Kyorin University
Language: English
Topic: Gut microbiota and health
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $5,620
Funders: Japan Agency for Medical Research and Development, Miyarisan Pharmaceutical, Keio University, Ministry of Education, Culture, Sports, Science and Technology, Ministry of Health, Labour and Welfare, Japan Society for the Promotion of Science, Core Research for Evolutional Science and Technology
OpenAlex ID: W2748314959
